PUBLISHER: IMARC | PRODUCT CODE: 1800841
PUBLISHER: IMARC | PRODUCT CODE: 1800841
Genomics Market Report by Component, Application, Technology, End-User, and Region 2025-2033
The global genomics market size reached USD 38.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 113.3 Billion by 2033, exhibiting a growth rate (CAGR) of 12.77% during 2025-2033. The market's main growth drivers are the increasing use of next-generation sequencing (NGS) in chronic diseases like cancer to detect genetic abnormalities and the rise in the prevalence of hereditary and viral disorders that require genomic sequencing. Additionally, the introduction of cutting-edge technologies in the genomics sector is enhancing applications and research. Furthermore, patient outcomes are being improved by the growing use of personalized medicine, which is driving the need for customized treatment regimens based on genomic information.
Genomics Market Analysis:
- Major Market Drivers: The genomics market size 2025 is experiencing growth driven by advancements in genetic sequencing technologies and an increasing interest in personalized medicine. Investments in R&D are pivotal, pushing the genomics market value upwards.
- Key Market Trends: Artificial intelligence (AI) and machine learning (ML) integration in genomics refer to the key genomics market trends, enhancing genomics market research capabilities. This trend aids in refining predictive modeling, leading to precise genomics market forecasts. The adoption of CRISPR gene editing technology highlights a significant shift in therapeutic applications, directly influencing genomics market demand.
- Geographical Trends: North America dominates in terms of genomics market revenue, due to its advanced healthcare infrastructure and a strong focus on research and innovation. The Asia-Pacific region shows the fastest genomics market growth rate, propelled by increasing government initiatives and a burgeoning focus on genomics research. This expansion offers a diverse genomics market overview, signaling varied growth prospects across different regions.
- Competitive Landscape: Notable market players in the genomics sector include Illumina, Inc., Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Oxford Nanopore Technologies, and CRISPR Therapeutics, among others. These entities are crucial in determining the genomics market outlook, with their competitive strategies and innovations significantly contributing to the market revenue.
- Challenges and Opportunities: Ethical concerns related to genetic data and the high costs associated with genomic sequencing pose challenges in the genomics market. Yet, these challenges also unveil opportunities for innovation to meet the increasing genomics market demand. Developing cost-effective sequencing methods and establishing ethical guidelines could further bolster the genomics market value and facilitate genomics market growth.
Genomics Market Trends:
Technological innovations in sequencing technologies
According to the genomics market analysis, the fast pace of innovative advancements, especially in next-generation sequencing (NGS) and CRISPR-Cas9 genome altering innovations, serves as an essential driver for the genomics showcase. The emergence of startups providing sequencing services for diverse uses, such as diagnostics, personalized medicine, and research. Sophisticated technologies like NGS have greatly improved genomic analysis, ensuring it is quicker, more precise, and economical. Government and industry funding are also vital in growing the market, aiding research efforts and the commercialization of innovative technologies. Examples like 23andMe, a prominent player in consumer genetic testing, and Genome Medical, which recently obtained $14 million in funding to enhance its telehealth genetic consultations, underscore the growing fusion of genomics and healthcare services. These advancements contribute to making genomics more attainable and usable, thereby making the global genomics market size 2025 experience significant growth.
Growing demand for personalized medicine
Another important driver of the market is the rising across the globe need for personalized medicine, which customizes medical care according to each patient's unique characteristics. Customized medical treatment depends greatly on genetic data to inform the creation of specific therapies tailored to an individual's genetic composition, moving away from the generalized approach of traditional medicine to more accurate and efficient treatments. This also facilitates enhanced awareness among consumers that helps them find an answer for the "what is the genomics market?" question. Along with this, the increasing need is fueled by the expanding recognition and knowledge of the genetic causes of diseases, the increasing frequency of genetic conditions, and the limitations of conventional therapies for various illnesses. Using genomics in personalized medicine aims to enhance patient results and provides a cost-effective healthcare approach by prioritizing prevention and accurate treatment, which drives more investments and research in genomics.
Expansion in clinical applications and diagnostics
The market is also growing due to genomics technologies being utilized more for clinical applications and diagnostics, such as identifying genetic disorders, cancer screening, and monitoring infectious diseases. Improved understanding of the genetic basis of diseases has allowed for the incorporation of genomics into clinical care, resulting in the creation of novel diagnostic tools and genetic tests that can anticipate an individual's risk for specific conditions, guide treatment choices, and track disease advancement. A question arises, what is the demand for genomics, particularly in the field of clinical applications and diagnostics? Advancements in genomics technologies are anticipated to keep driving demand in this field, expanding their potential in diagnostics such as liquid biopsies and NIPT, highlighting the critical role genomics plays in revolutionizing healthcare and diagnostics.
Genomics Market Segmentation:
Breakup by Component:
- Products
- Instruments and Software
- Consumables and Reagents
- Services
- Core Genomics Services
- NGS-Based Services
- Biomarker Translation Services
- Computational Services
- Others
Consumables and reagents account for the majority of the market share
The consumables and reagents sector dominates the market due to their essential role in a variety of genomic procedures including DNA sequencing, gene editing, and sample preparation. With the increased use of genomics in sectors such as healthcare, agriculture, and biotechnology, there is a rising need for specific consumables and reagents, leading manufacturers to enhance and extend their product range. This is promoting the development of the consumables industry, emphasizing its crucial role in driving and applying genomics technologies, making a substantial contribution to the market's overall growth. Moreover, the strong demand for these products, which are essential for ensuring the accuracy and reliability of genomic analyses in research and clinical diagnostics, further solidifies the dominance of this industry sector.
Breakup by Application:
- Functional Genomics
- Epigenomics
- Biomarkers Discovery
- Pathway Analysis
- Others
Functional genomics holds the largest share of the industry
Functional genomics, which focuses on gene functions and interactions, has become the dominant area in the market, showcasing its crucial importance in comprehending intricate biological processes and disease mechanisms. Utilizing high-throughput technologies including RNA sequencing and CRISPR-Cas9 in functional genomics enables in-depth study of gene expression and regulation, leading to progress in biomedical research and healthcare. Moreover, the growing emphasis on exploring the functional characteristics of the genome, along with the quick advancements in technology, positions functional genomics as a major force driving growth and innovation in the overall market.
Breakup by Technology:
- Sequencing
- Microarray
- Polymerase Chain Reaction
- Nucleic Acid Extraction and Purification
- Others
Sequencing represents the leading market segment
Sequencing technology is the main component of the market due to its crucial role in deciphering the genetic information found in DNA and RNA, making it the largest technological segment. The critical insights provided by sequencing drive this prominence in personalized medicine, genetic research, and diagnostic applications by uncovering genetic variations and mutations. Furthermore, the rise of NGS technologies is changing this field by offering unparalleled speed, accuracy, and cost-efficiency compared to traditional techniques. NGS enables a detailed analysis of genomes, exomes, and transcriptomes, allowing for progress in comprehending complex diseases, evolutionary biology, and microbial genomics.
Breakup by End-User:
- Research Centers
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
Pharmaceutical and biotechnology companies exhibit a clear dominance in the market
Pharmaceutical and biotechnology companies are playing a major role in the market, emphasizing their significance in driving drug development and personalized medicine forward. These areas apply genomic data to identify novel targets for drugs, understand the genetic origins of diseases, and develop tailored treatments using individuals' genetic data. For instance, Illumina Inc., a top company in DNA sequencing and array-based technologies worldwide, partnered with Nashville Biosciences, LLC, a prominent clinical and genomic data company that is a subsidiary of Vanderbilt University Medical Center (VUMC), to reveal the five original members of the Alliance for Genomic Discovery (AGD). The extended agreement aims to quicken the treatment development process by conducting thorough genomics research and establishing a high-quality clinical genomics database. AbbVie, Amgen, AstraZeneca, Bayer, and Merck will pool their resources to fund the sequencing of 250,000 samples and can use the data for developing drugs and improving therapies.
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
North America leads the market, accounting for the largest genomics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for genomics.
North America holds the largest market share due to its advanced healthcare system, significant investment in research and development, and the presence of top pharmaceutical and biotechnology companies. Additionally, the region's advanced technology in genomics and bioinformatics, along with these factors, is fostering a favorable environment for the development and advancement of the genomics field. North America's strong position in the global market is supported by the close collaboration between academic and research institutions with the industry, leading to innovation and setting trends that impact global genomics practices and policies.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the genomics industry include
- 23andMe, Inc
- Agilent Technologies, Inc.
- Bayer AG
- BGI Group
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Illumina, Inc.
- Oxford Nanopore Technologies
- PerkinElmer, Inc.
- Myriad Genetics, Inc.
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
Major players in the industry are involved in various strategic activities to uphold and strengthen their market presence. These businesses are making significant investments in research and development to launch new genomic technologies, services, and solutions that cater to their customers' changing needs. Working together, forming partnerships, and making acquisitions are important strategies that enable them to enhance their technological capabilities, enter new markets, and gain new genomic applications and intellectual property. Additionally, these top companies are focusing on improving their bioinformatics systems to manage and analyze the large amounts of data generated from genomic sequencing. This enables full solutions that help translate genomic findings into progress in clinical and agricultural sectors.
Key Questions Answered in This Report
- 1.What is the genomics market?
- 2.How big is the genomics market?
- 3.What is the market forecast for genomics?
- 4.What are the key factors driving the global genomics market?
- 5.What has been the impact of COVID-19 on the global genomics market?
- 6.What is the breakup of the global genomics market based on the component?
- 7.What is the breakup of the global genomics market based on the application?
- 8.What is the breakup of the global genomics market based on the technology?
- 9.What is the breakup of the global genomics market based on the end-user?
- 10.What are the key regions in the global genomics market?
- 11.Who are the key players/companies in the global genomics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Genomics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Component
- 6.1 Products
- 6.1.1 Market Trends
- 6.1.2 Major Types
- 6.1.2.1 Instruments and Software
- 6.1.2.2 Consumables and Reagents
- 6.1.3 Market Forecast
- 6.2 Services
- 6.2.1 Market Trends
- 6.2.2 Major Types
- 6.2.2.1 Core Genomics Services
- 6.2.2.2 NGS-Based Services
- 6.2.2.3 Biomarker Translation Services
- 6.2.2.4 Computational Services
- 6.2.2.5 Others
- 6.2.3 Market Forecast
7 Market Breakup by Application
- 7.1 Functional Genomics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Epigenomics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Biomarkers Discovery
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Pathway Analysis
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Technology
- 8.1 Sequencing
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Microarray
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Polymerase Chain Reaction
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Nucleic Acid Extraction and Purification
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by End-User
- 9.1 Research Centers
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Hospitals and Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Pharmaceutical and Biotechnology Companies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 23andMe, Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 Agilent Technologies, Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Bayer Aktiengesellschaft
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 BGI Genomics Co. Ltd.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.5 Bio-RAD Laboratories Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Danaher Corporation
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Illumina Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Oxford Nanopore Technologies
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 PerkinElmer Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Myriad Genetics Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 Roche Holding AG
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.12 Thermo Fisher Scientific Inc.
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.1 23andMe, Inc.
List of Figures
- Figure 1: Global: Genomics Market: Major Drivers and Challenges
- Figure 2: Global: Genomics Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Genomics Market: Breakup by Component (in %), 2024
- Figure 4: Global: Genomics Market: Breakup by Application (in %), 2024
- Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2024
- Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2024
- Figure 7: Global: Genomics Market: Breakup by Region (in %), 2024
- Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 9: Global: Genomics (Products) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 11: Global: Genomics (Services) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 41: North America: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 42: North America: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 43: United States: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 44: United States: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 45: Canada: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 49: China: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 50: China: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 51: Japan: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 53: India: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 54: India: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 55: South Korea: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 57: Australia: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 59: Indonesia: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 61: Others: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 62: Others: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 63: Europe: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 65: Germany: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 67: France: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 68: France: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 69: United Kingdom: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 71: Italy: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 73: Spain: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 75: Russia: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 77: Others: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 78: Others: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 79: Latin America: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 81: Brazil: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 83: Mexico: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 85: Others: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 86: Others: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 89: Global: Genomics Industry: SWOT Analysis
- Figure 90: Global: Genomics Industry: Value Chain Analysis
- Figure 91: Global: Genomics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Genomics Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million USD), 2025-2033
- Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million USD), 2025-2033
- Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
- Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million USD), 2025-2033
- Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 7: Global: Genomics Market: Competitive Structure
- Table 8: Global: Genomics Market: Key Players
